In a groundbreaking collaboration with C-MET, Lord's Mark Industries Limited is making strides in breast cancer screening technology. Utilizing advanced AI and thermal sensors, they are set to launch trials in the USA, Great Britain, and Europe. The promising results from clinical trials in India indicate a strong potential for regulatory approval, with plans to enhance affordability and access for underserved communities ahead of anticipated final trials in January 2027.
RSS News
Economic times
0 thoughts on “Lord’s Mark advances AI breast cancer screening towards clinical trials”
Leave a Reply
Your email address will not be published. Required fields are marked *
RECENT NEWS
- 13th driest monsoon in the country: Punjab received 41% less rainfall, Rajasthan 21% deficit; Monsoon to withdraw from the country by October 10
- India-UAE oil pipeline to be built in the Arabian Sea to Gujarat-Maharashtra
- What time is the ODI World Cup 2027 schedule announced today, will India and Pakistan be in a group?
- N. Raghuraman's column: What fathers once used to do spontaneously, schools are now doing scientifically
- IND vs WI: How much money did Shubman Gill get as a prize for a tumultuous innings of 223 runs?
